Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

1.890 -0.110 (-5.50%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 570,475
Open 2.000
Bid (Size) 1.850 (10,000)
Ask (Size) 1.900 (200)
Prev. Close 2.000
Today's Range 1.800 - 2.015
52wk Range 1.330 - 3.470
Shares Outstanding 31,056,238
Dividend Yield N/A

Performance

YTD
-3.1%
-3.1%
1 Month
+31.2%
+31.2%
3 Month
+16.7%
+16.7%
6 Month
-6.0%
-6.0%
1 Year
-40.2%
-40.2%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 1.890
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 01/07/26 04:00 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 58.70M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 59M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.